FDA Clears SmartSpeed Precise MRI Software from Philips
The deep learning reconstruction software reportedly facilitates accelerated MRI scanning and significantly enhanced image sharpness.
The Food and Drug Administration (FDA) has granted 510(k) clearance for SmartSpeed Precise software, which may enable significantly reduced scan times and advanced image clarity for magnetic resonance imaging (MRI).
Emphasizing a one-click workflow, the SmartSpeed Precise MRI software combines the Compressed SENSE acceleration technology with dual artificial intelligence (AI) engines for denoising and image sharpening, according to Philips, the manufacturer of SmartSpeed Precise.
Here one can see images from a seven-second brain MRI exam performed with the use of the recently FDA-cleared SmartSpeed Precise software. (Images courtesy of Philips.)
Philips maintained the use of SmartSpeed Precise MRI software, which is available for Philips 1.5T and 3T MRI system, enables a threefold acceleration of MRI scan time and up to an 80 percent improvement in image sharpness.
“SmartSpeed Precise helps us do what was previously thought impossible—deliver sharper, faster MRI with less effort,” added Julian Luetkens, M.D., a professor of radiology at University Hospital Bonn in Bonn, Germany. “In breast MRI, we saw acquisition times reduced by up to 50%, with image quality improving compared to previous Compressed SENSE protocols. That’s a game-changer.”
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
